Medtronic announces FDA clearance for LigaSure™ RAS Maryland instrument on the Hugo™ RAS system
Medtronic received FDA clearance for the LigaSure RAS Maryland jaw device for use with the Hugo robotic-assisted surgery system, bringing its vessel-sealing technology to U.S. robotic procedures for the first time. The instrument is the first robotic-driven LigaSure device, sealing vessels up to 7 mm in diameter in roughly 2 seconds on the Valleylab FT10 platform; it launched in Europe in 2025 under CE Mark and builds on vessel-sealing technology used in more than 45 million procedures across 65+ countries. The Hugo RAS system is currently cleared in the U.S.
Key figures
- Europe launch
- 2025 following CE Mark
- Vessel seal time
- approximately 2 seconds
- Ligasure countries
- 65+
- Vessel seal max diameter
- 7 mm
- Hugo countries outside us
- 35+
- Ligasure procedures to date
- more than 45 million
- Hugo surgical procedures outside us
- 50+
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.